Clinical Study Protocol, published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot2 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/vulcan-udp-ig/ and changes regularly. See the Directory of published versions
| Page standards status: Informative |
Profile: M11 Research Study Profile
M11_ProtocolSummary
url
objectiveAndEstimandSummaryvalue: The primary objective of this study is to see if Inhaled Exoticillin achieves similar or better results compared to intramuscular Exoticillin when treating Bronchtis in Japanese Patients who also have Iatrogenic Diabetes Mellitus. The seconday objective is to evaluate the cost differences in treatment. Evaluation will be by recording the average days to recovery, the total combined cost of medication and cost of hospital stay.
url
interventionModelvalue: Parallel Group
url
populationTypevalue: With Disease
url
controlTypevalue: Different Dose or Regimen
url
comparatorvalue: MedicinalProductDefinition: identifier = Sponsor's Investigational Product Code: EX2010/12
url
minimumAgevalue: 18 Years (Details: NCI Thesaurus codeC29848 = 'C29848')
url
maximumAgevalue: 55 Years (Details: NCI Thesaurus codeC29848 = 'C29848')
url
interventionAssignmentMethodvalue: Randomisation
url
randomisationTypevalue: block randomisation
url
otherInterventionAssignmentMethodvalue:
url
stratificationIndicatorvalue: Yes
url
siteDistributionvalue: Multicentre
url
siteGeographicScopevalue: Multiple Countries
url
masterProtocolIndicatorvalue: No
url
drug-DeviceCombinationProductIndicatorvalue: Yes
url
adaptiveTrialDesignIndicatorvalue: No
url
numberOfArmsvalue: 2
url
trialBlindSchemavalue: Observer Blind
url
blindedRolesvalue: Participant
url
blindedRolesvalue: Care Provider
url
targetOrMaximumvalue: Target
url
numberOfParticipantsvalue: 200
url
alternateDescriptionOfPlannedDurationOfTrialInterventionvalue: Will depend on response to treatment
url
totalPlannedDurationOfTrialParticipationvalue: 3 Months (Details: NCI Thesaurus codeC29846 = 'C29846')
url
independentCommitteesvalue: Independent Data Monitoring Committee
url
independentCommitteesvalue: Other
url
otherCommitteesvalue: Exemplar Monitoring Board
url
trialSchemaurl
schemaNotesvalue: Hic textus tantummodo locum tenens est. Nullum verum sensum habet praeter spatium in pagina vel velo implere. Utile tamen est ad rem illustrandam. Huiusmodi ineptiae plerumque cum \"lorem ipsum\" incipiunt, sed ita translatae non sunt textus laetus.
url
scheduleofActivitiesurl
populationDiagnosisOrConditionurl
unitsOfMinimumAgeurl
unitsOfMaximumAgeurl
totalPlannedDurationOfTrialInterventionurl
alternateDescriptionOfPlannedDurationOfTrialParticipationurl
additionalDescriptionofDuration
M11 Research Study Extension
url
originalProtocolurl
versionDate
identifier: Sponsor Protocol Identifier/ABC-Exemplar (use: usual, )
status: Active
| Reference |
| MedicinalProductDefinition: identifier = Sponsor's Investigational Product Code: EX2015/03 |
condition: Bronchitis (disorder), Iatrogenic hypoglycaemia